Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-08-22 23:12 | 2012-08-21 | CVS | CVS HEALTH Corp | MILLON JEAN PIERRE | Director | Retail-Drug Stores and Proprietary Stores | OPT+S | $45.73 | 33,726 | $1,542,290 | 0 | -100.0% |
| 2011-11-19 00:04 | 2011-11-16 | CVS | CVS HEALTH Corp | MILLON JEAN PIERRE | Director | Retail-Drug Stores and Proprietary Stores | OPT+S | $38.90 | 33,739 | $1,312,575 | 0 | -100.0% |
| 2010-03-24 21:13 | 2010-03-22 | INHI-OB | InfuSystem Holdings, Inc | MILLON JEAN PIERRE | Director | Surgical & Medical Instruments & Apparatus | BUY | $0.00 | 1,714 | $0 | 268,806 | +0.6% |
| 2010-03-24 21:13 | 2010-03-22 | INHI-OB | InfuSystem Holdings, Inc | MILLON JEAN PIERRE | Director | Surgical & Medical Instruments & Apparatus | SALE | $0.00 | 42,858 | $0 | 267,092 | -13.8% |
| 2007-11-16 00:30 | 2007-11-14 | CVS | CVS HEALTH Corp | MILLON JEAN PIERRE | Director | Retail-Drug Stores and Proprietary Stores | OPT+S | $42.28 | 28,364 | $1,199,289 | 8,617 | -76.7% |
| 2007-05-14 23:14 | 2007-05-11 | CVS | CVS HEALTH Corp | MILLON JEAN PIERRE | Director | Retail-Drug Stores and Proprietary Stores | SALE | $37.30 | 8,946 | $333,686 | 7,586 | -54.1% |
| 2005-11-18 01:37 | 2005-11-16 | CMX | N/A | MILLON JEAN PIERRE | Director | Other | OPT+S | $49.86 | 20,000 | $997,100 | 0 | -100.0% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.